NeueHealth (NEUE) Competitors

NeueHealth (NYSE:NEUE) and Roadzen (NASDAQ:RDZN) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, profitability, analyst recommendations, risk, valuation, dividends and community ranking.

Is NEUE or RDZN more profitable?

NeueHealth has a net margin of -36.28% compared to Roadzen's net margin of -248.79%. Roadzen's return on equity of 0.00% beat NeueHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeueHealth	-36.28%	-6.40%	8.45%
Roadzen	-248.79%	N/A	-269.99%

Which has more volatility and risk, NEUE or RDZN?

NeueHealth has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500. Comparatively, Roadzen has a beta of 0.24, indicating that its share price is 76% less volatile than the S&P 500.

Do analysts recommend NEUE or RDZN?

NeueHealth currently has a consensus price target of $7.00, indicating a potential upside of 11.11%. Roadzen has a consensus price target of $5.00, indicating a potential upside of 367.29%. Given Roadzen's stronger consensus rating and higher possible upside, analysts clearly believe Roadzen is more favorable than NeueHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeueHealth	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Roadzen	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the MarketBeat Community favor NEUE or RDZN?

Roadzen received 3 more outperform votes than NeueHealth when rated by MarketBeat users. Likewise, 100.00% of users gave Roadzen an outperform vote while only 0.00% of users gave NeueHealth an outperform vote.

Company	Underperform	Outperform
NeueHealth	Outperform Votes No Votes	Underperform Votes 2 100.00%
Roadzen	Outperform Votes 3 100.00%	Underperform Votes No Votes

Do insiders and institutionals hold more shares of NEUE or RDZN?

63.9% of NeueHealth shares are held by institutional investors. Comparatively, 24.7% of Roadzen shares are held by institutional investors. 64.3% of NeueHealth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Which has higher valuation & earnings, NEUE or RDZN?

Roadzen has lower revenue, but higher earnings than NeueHealth. Roadzen is trading at a lower price-to-earnings ratio than NeueHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeueHealth	$936.66M	0.06	-$1.15B	-$22.63	-0.28
Roadzen	$42.89M	1.85	-$99.67M	-$1.51	-0.71

Does the media favor NEUE or RDZN?

In the previous week, NeueHealth had 2 more articles in the media than Roadzen. MarketBeat recorded 6 mentions for NeueHealth and 4 mentions for Roadzen. Roadzen's average media sentiment score of 0.25 beat NeueHealth's score of -0.33 indicating that Roadzen is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeueHealth	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Roadzen	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Roadzen beats NeueHealth on 10 of the 18 factors compared between the two stocks.